Background: Psoriasis is a chronic, immune mediated inflammatory condition that affects a significant amount of the global population. Yet geographic variability in the consequences of psoriasis warrants region-level analyses. oBjective: The current study contributes to the psoriasis outcomes literature by offering a comprehensive assessment of the humanistic and economic burden in Brazil. Methods: The 2012 Brazil National Health and Wellness Survey (N=12,000) was used to assess health-related quality of life (Short Form-12, version 2), work productivity, and healthcare resource use associated with experiencing psoriasis vs. no psoriasis, along with varying levels of psoriasis severity. results: A total of 210 respondents reported diagnosis of psoriasis (N=157, 42, and 11 reporting mild, moderate, and severe psoriasis, respectively). Compared with controls, respondents with psoriasis reported diminished mental component summary scores and health utilities, as well as increased presenteeism, activity impairment, and physician visits over the past six months, adjusting for covariates. Among those with psoriasis, physical health decreased as psoriasis severity increased. Although work productivity and healthcare resource utilization did not differ with psoriasis severity, the high rates of productivity loss (e.g. 45.5% presenteeism in the severe psoriasis group) suggest an economic burden. study liMitations: Cost analyses were not performed, and cross-sectional patient-reported data limit causal conclusions and may reflect reporting biases. conclusions: Nevertheless, these results suggest a significant burden to patients with psoriasis across both humanistic and economic outcomes. The association between psoriasis and mental health aspects and health utilities were particularly strong and exceeded what would be considered clinically meaningful.
INTRODUCTION
Psoriasis is a chronic, immune-mediated inflammatory condition characterized by inflamed, scaly lesions that can affect any area of the skin. 1 Prevalence studies conducted around the world show that psoriasis generally occurs in less than 5% of the population. [2] [3] [4] [5] [6] [7] Yet, other reviews report substantial geographic variation, with a higher prevalence occurring in countries farther away from the equator. 2, 8 For example, one review reported a prevalence of 0.91% in the US compared with 8.5% in Norway. 2 Psoriasis is a systemic disease, but seldom a life-threatening one. To date, there is no treatment cure and therapeutic strategies aim solely to reduce symptoms and maintain/improve health-related quality of life (HRQoL). Indeed, psoriasis can have a signif-
The association between psoriasis and health-related quality of life, work productivity, and healthcare resource use in Brazil icant effect on HRQoL and other outcomes. Patients with psoriasis experience physical discomfort, impaired emotional functioning, negative body image, and daily activity impairments. 9 Studies of patients in the United States (US) have found that increased severity was associated with decrements in HRQoL, more healthcare provider visits, and frustration with treatment. 10, 11 Even when psoriasis severity is mild, patients report the disease as a significant problem in their daily lives. 12 The chronic and recurrent nature of the disease requires life-long treatment, which leads to significant economic burden on patients and the healthcare system. Significant increases in healthcare resource utilization and costs have been observed and work productivity also suffers. 13 A study conducted in the UK found that 59% of patients with psoriasis reported a high degree of absenteeism (almost one month of work lost per year).
14 Between 34%-92% of patients with psoriasis who were unemployed in the US and the UK reported that their inability to work was due to their condition. 14, 15 However, few studies have examined psoriasis in South
America. There is little consensus on whether the prevalence there is lower or comparable relative to other regions indicating that more work is required in this region. 2, [6] [7] [8] 16, 17 Research is also needed for better documenting the humanistic and economic burden associated with psoriasis in this part of the world, as its effect on the patient may exhibit a similar geographic variation as its very prevalence.
The current study focuses on Brazil. Explorations of psoriasis in Brazil are often limited to convenience samples of patients arriving at public clinics for treatment. [18] [19] [20] Nevertheless, this emerging research suggests patients in Brazil are often overweight or obese, report diminished HRQoL, report increased daily activity impairment, seek multiple healthcare providers' treatment, and report being dissatisfied with treatment course. [18] [19] [20] When psoriasis patients do continue with a prescribed course of treatment, HRQoL improves as long as clinical improvements are also shown. 21 One study of outpatients in Brazil with psoriasis found that decrements in HRQoL were due to physical symptoms and negative feelings causing heightened distress. 22 Another study with patients in Brazil distinguished psoriasis from other skin diseases (e.g. vitiligo) by
showing that psoriasis more often elicited coping strategies such as control of emotions and stress avoidance. 23 Although the literature is generally rich in research suggesting a significant burden of psoriasis, more work is needed. Given the observed geographic variability with respect to prevalence, it is possible the effect of psoriasis on the patient may also vary by region. The aim of this study was to extend the current body of research conducted in Brazil by using the Brazil National Health and Wellness Survey, a general health survey of adults in Brazil, to assess the association between psoriasis, psoriasis severity, and an array of health outcomes, both humanistic and economic.
METHODS

Data source and procedures
Data from the Brazil 2012 National Health and Wellness Survey (NHWS) were used in the analyses. NHWS is a self-administered, cross-sectional health survey of adults aged 18 years and older in Brazil. Data were collected using a dual methodology of Internet and computer-assisted Web interviewing (CAWI).
This dual approach was used to minimize bias related to Internet access, particularly among the elderly. Invitations to participate in the Brazil NHWS were sent to members of the Lightspeed Research
Internet panel via e-mail, and the survey was administered online.
Additionally, some respondents (especially those aged 65+ years)
were recruited to complete the survey at a centralized facility or in the respondents home. In these cases, trained interviewers assisted the participants with inputting their answers into a computer which had the same interface as those who completed the survey online.
A stratified, random sampling procedure (for all participants) was implemented according to gender and age strata (based on the In- HRQoL. HRQoL was measured using the Short Form-12
(version 2) [SF-12v2], a 12-item instrument with strong evidence for reliability and validity. 26 The items from the SF-12v2 are used to cre- 
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Only respondents who reported being employed provided data for absenteeism, presenteeism, and overall work impairment. Percentage of time missed due to absenteeism, presenteeism, and overall work impairment was converted into days per year by multiplying each percentage by 234 days (52 working weeks per year × 5
working days per week -26 days of paid annual leave). All respondents provided data for activity impairment, which was assessed by whether a respondent required assistance from another person in daily activities including taking care of children, getting dressed, bathing yourself, doing everyday chores, and lifting objects heavier than a loaf of bread.
Healthcare resource use. The number of physician visits, emergency room (ER) visits, and hospitalizations in the past six months were also reported by each respondent. These were not specific to psoriasis.
Statistical analyses
Demographic and patient characteristic differences between those with psoriasis and those without psoriasis as well as among those with varying levels of psoriasis severity (mild vs. moderate vs.
severe) were examined using chi-square tests and one-way ANOVA Summaries of regression models used to predict health outcomes from psoriasis diagnosis (yes vs. no) and psoriasis severity (mild vs. moderate vs. severe) are presented (Tables 5 and 6 ). With respect to HRQoL, the greatest differences between patients with psoriasis and those without was on MCS and health utilities, both of which exceeded clinically relevant cutoffs. The values from our study were comparable to psoriasis studies conducted in the US that used either the SF-12v2 or SF-36v2. [30] [31] [32] The effects for MCS and health utilities did not significantly vary by severity, though there was a trend for worse outcomes among those who were severe relative to those who were mild. PCS was not significantly different between patients with psoriasis and controls, though differences across severity were observed as also reported in past literature. 30 This pattern of results suggests that the presence itself of psoriasis may result in a significant mental health burden (due to the stigma of the condition, social anxiety, etc), but greater severity does not appreciably influence the size of this burden. Conversely, with most patients in our sample being of mild severity, the physical burden is not particularly debilitating unless the condition is severe. This lack of physical burden may also be a function of the greater healthcare access of patients with psoriasis. Although our analyses controlled for socioeconomic-related variables, it is possible that the health care these patients receive (for all their conditions) may be better than control participants; this could mask some of the underlying physical burden of psoriasis itself.
Results for the work productivity indices varied in its similarity to past work. Although rates of impairment were comparable to other studies, these rates did not differ from controls. 14, [18] [19] [33] [34] [35] [36] [37] In part, this may be a sample size limitation (only 150 patients with psoriasis were currently employed); rates of impairment were generally a third higher among those with psoriasis compared with those without. Nevertheless, activity impairment was significantly higher among those with psoriasis. None of these variables varied significantly by severity; however, the trends suggest a potential effect for some of these variables. For example, patients with severe psoriasis experience a particularly high rate of presenteeism (45.5%) compared to the mild psoriasis group (21.4%).
Although the number of hospitalizations and emergency room visits were statistically identical for those with psoriasis and those without psoriasis, approximately 25% more physician visits were reported among those with psoriasis. The number of visits did not vary by severity.
As study limitation, all data from the NHWS were patient-reported, so no clinical verification of diagnosis, comorbidities, or healthcare resource use was available. Additionally, because the NHWS is a cross-sectional study, a causal relationship between psoriasis and outcomes measured can only be speculated from the available data. Although the NHWS provides a broad demographic representation of the Brazilian adult population, our sample of patients with psoriasis may not generalize to the population of patients with psoriasis. Indeed, our distribution of severity skewed towards the milder category suggesting our estimates of disease burden may be underestimates. Furthermore, compared with the general Brazil population, NHWS has a smaller proportion of respondents from lower-socioeconomic strata, reflecting people with the motivation, ability, and access to participate in an online survey. Therefore, NHWS respondents tend to be wealthier and better educated, such that the current study results may not generalize to the broader Brazil population or the low income population in particular.
CONCLUSION
In sum, these results suggest a significant burden of patients with psoriasis across both humanistic and economic outcomes. The association between psoriasis and mental health aspects and health utilities were particularly strong and exceeded what would be considered clinically meaningful. Although cost analyses were not performed in this study, these results suggest a significant economic burden from a societal perspective. It is also worth noting that this burden may be underestimated as respondents with better socioeconomic status and healthcare access were more likely to be diagnosed; it is likely a number of patients from the control group have psoriasis but have not been diagnosed.
Understanding the full extent of the burden of psoriasis in Brazil will aid in facilitating public awareness, doctor-patient relationships, and beneficial healthcare policies. Despite universal healthcare in Brazil (Unified Health System; i.e., SUS), past studies have outlined the challenges psoriasis patients experience in receiving adequate care in Brazil. 18 Using humanistic and economic indicators of the burden of psoriasis, this study researched a national sample representative of the adult population in Brazil, a critical extension of past work that has typically relied on small convenience samples. q
